Meeting
2019 ASCO Quality Care Symposium
Treatment decision-making and financial toxicity in metastatic breast cancer.
Authors
Clara Wan
University of Alabama at Birmingham, Birmingham, AL
Clara Wan, Courtney Williams, Stacey A. Ingram, Valerie Lawhon, Jennifer Young Pierce, Kendal Dekle, Janel Lowman, Jonathan Jones, Andres Azuero, Aidan Gilbert, Gabrielle Betty Rocque
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cost, Value, and Policy; Health Equity and Disparities
Track
Cost, Value, and Policy,Health Care Access, Equity, and Disparities
Sub Track
Value/Cost of Care
Citation
J Clin Oncol 37, 2019 (suppl 27; abstr 97)
DOI
10.1200/JCO.2019.37.27_suppl.97
Abstract #
97
Poster Bd #
G12
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Quality Care Symposium
Financial toxicity of front-line platinum etoposide plus atezolizumab versus durvalumab in extensive-stage small-cell (ES-SCLC) lung cancer.
First Author: Bradley Harrison
Poster
2021 ASCO Quality Care Symposium
Assessing financial toxicity in patients with metastatic breast cancer: A single institution experience during the COVID-19 pandemic.
First Author: Shruti Sinkar
Poster
2019 ASCO Quality Care Symposium
Meeting lung cancer value based care requirements with documentation of patient goals and preferences.
First Author: Avnish K Bhatia
Poster
2019 ASCO Annual Meeting
Desire to address costs at time of treatment decisions among patients with metastatic breast cancer.
First Author: Yvonne Y. Lei